General Principles of Control and Pathway Coordination
Pyrimidine biosynthesis is tightly controlled to meet cellular demands. It relies on allosteric regulation, in which molecules bind to enzymes outside their active sites, altering their conformation and, consequently, their activity.
A crucial link between purine and pyrimidine synthesis is PRPP (5-phosphoribosyl-1-pyrophosphate). This compound serves not only as a substrate but also as a potent activator for both pathways. However, when nucleotides become too abundant, they exert negative feedback to block the formation of PRPP itself. In this way, the cell prevents the wasteful expenditure of resources on producing excess building blocks for nucleic acids.
Control of CAD Enzyme Activity
The initial steps of synthesis are carried out by the multifunctional CAD enzyme complex, which possesses multiple catalytic domains. Regulation targets two key activities of this complex:
- Carbamoyl phosphate synthetase II (CPS II) activity:
- Activation: Stimulated by PRPP. This serves as a chemical signal that the cell has an adequate carbohydrate substrate pool to form nucleotides.
- Inhibition: Suppressed by UTP and UMP. The accumulation of these substances indicates that the pathway's end products have been produced in sufficient amounts.
- Aspartate transcarbamylase (ATCase) activity:
- Activation: Enhanced by ATP. A high concentration of ATP signals to the cell that energy is available and the purine pool is sufficient, necessitating accelerated pyrimidine synthesis to maintain balance.
- Inhibition: Blocked by CTP, which is one of the pathway's end products.
Regulation of UMP Synthase and CTP Synthetase
Subsequent steps of biosynthesis involve other enzymes that are also subject to feedback control:
- UMP synthase is the second multifunctional enzyme in this pathway. The main target for regulation here is its OMP decarboxylase activity. It is specifically inhibited by monophosphates—UMP and CMP. Activity decreases as these products accumulate in the cytosol.
- CTP synthetase is responsible for the final conversion of UTP to CTP. This enzyme is inhibited by CTP itself. By blocking its own formation from UTP, CTP prevents the uncontrolled depletion of uridine nucleotide reserves.